Status:
COMPLETED
Etiology and Prognosis of sICH Based on Hemorrhage Location
Lead Sponsor:
Jinling Hospital, China
Conditions:
Spontaneous Intracerebral Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
The investigators retrospectively collected participants with spontaneous cerebral hemorrhage(sICH) from January 2015 to December 2019 for training and internal validation. Clinical and imaging data w...
Eligibility Criteria
Inclusion
- The confirmation of intracranial hemorrhage was achieved through NCCT.
Exclusion
- They presented with secondary hemorrhage resulting from head trauma, hemorrhagic transformation of ischemic infarction, brain tumors, or exhibited abnormalities in blood coagulation, liver, kidney function, or were subject to drug-induced cerebral hemorrhage
- Only postoperative CT images were available
- Lost follow-up records
- CT image artifacts
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
698 Patients enrolled
Trial Details
Trial ID
NCT06498778
Start Date
July 1 2021
End Date
May 31 2023
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinling Hospital
Nanjing, Jiangsu, China